Cash And Equivalent تغيير تاريخ
Acadia Pharmaceuticals USD 755.99M 190.66M 2024-12
Adcock Ingram Holdings ZAR 79.14M 10.28M 2024-12
Agios Pharmaceuticals USD 78.96M 2.72M 2025-03
Alnylam Pharmaceuticals USD 1.02B 53.23M 2025-03
Amgen USD 8.81B 3.16B 2025-03
Arrowhead Research USD 51.79M 47.4M 2024-12
Biogen USD 2.6B 223.3M 2025-03
BioMarin Pharmaceutical USD 612.03M 1.19M 2025-03
Celltrion KRW 972.66B 68.24B 2024-09
Cspc Pharmaceutical 8.37B 3.64B 2024-06
Dianthus Therapeutics USD 22.79M 10.88M 2024-12
Gilead Sciences USD 7.93B 2.06B 2025-03
GlaxoSmithKline GBP 4.46B 594M 2025-03
Incyte USD 2.41B 720.83M 2025-03
Ionis Pharmaceuticals USD 264.19M 22.12M 2025-03
Kangmei Pharma CNY 773.51M 28.83M 2024-09
Knight Therapeutics CAD 5.81M 3.59M 2024-09
Laboratorios Farma EUR 27.19M 17.39M 2024-12
Malin Corporation EUR 35.7M 6.4M 2024-06
Moderna USD 1.62B 304M 2025-03
Pharma Mar EUR 60.29M 2.95M 2025-03
Qiagen NV USD 663.56M 309.42M 2024-12
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Sarepta Therapeutics USD 1.1B 905.16M 2024-12
Sartorius EUR 839.5M 26.1M 2025-03
Sino Biopharmaceutical CNY 8.55B 902.41M 2024-06
Tilray USD 189.7M 15.49M 2024-11
Ultragenyx Pharmaceutical USD 173.73M 23.11M 2024-12
United Therapeutics USD 1.9B 202.7M 2025-03
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12
Zz Pientze Pharmaceu 1.39B 93.82M 2025-03



Moderna النقدية وما يعادلها - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.